ArticleCureus2025
Pericardial Effusion as an Early Manifestation of Myeloperoxidase (MPO)-Positive Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis With Eosinophilia.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is a rare but life-threatening autoimmune disease that primarily targets the kidneys and lungs. Cardiac involvement is far less common, and when it does occur, it is often overlooked until late in the disease course. We describe an elderly man who presented with acute breathlessness, pericardial effusion, eosinophilia, and worsening renal function. Initial management of pneumonia proved ineffective, and further investigation revealed strongly positive myeloperoxidase (MPO)-ANCA antibodies. The diagnosis of MPO-positive AAV with eosinophilia was established. Following treatment with corticosteroids and rituximab, the patient showed complete resolution of the effusion and significant recovery of renal function. This case highlights the diagnostic challenge of pericardial effusion as an early clue to systemic vasculitis and underscores the importance of early recognition and prompt immunosuppressive therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.